level-one heading

Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 150 /hr
Hire Dr. Lars B.
Switzerland
USD 150 /hr
Profile Summary
Subject Matter Expertise
Services
Work Experience

Owner

LJB Adamantine Science

September 2013 - Present

Owner

LJB Adamantine Science

January 2013 - Present

Interim Senior Director, Bioinformatics

Retroscreen Virology ltd

December 2013 - July 2014

Consultant Senior ``research Scientist

AstraZeneca R and D Mölndal

February 2013 - October 2013

Consultant Senior Scientist, assay development

Astrazeneca

February 2013 - September 2013

Director, Yale Center for High Throughput Cell Biology

Yale University

June 2008 - July 2010

Director, Yale Center for High Throughput Cell Biology

Yale University

May 2008 - June 2010

Associate Director, Chemical Genetics

Columbia University

September 2005 - June 2008

Director, Columbia University MLSCN Center

Columbia University

March 2004 - June 2008

Associate Director, Chemical Genetics

Columbia University

October 2005 - May 2008

Director, Columbia MLSCN Center

Columbia University

May 2004 - May 2008

Research Fellow

Memorial Sloan-Kettering Cancer Center

August 2002 - April 2004

Project Manager

Karolinska Institutet-Huddinge Campus

May 2001 - July 2002

Education

Associate, Art

Ölands konstskola

August 2010 - June 2012

PhD, Cell- and Molecular Biology (CBT, Clinical Research Center, Dept. of Immunology)

Karolinska Institutet-Huddinge Campus

February 1996 - June 2001

N/A (Life Sciences)

Lunds Universitet

- September 1996

MSci

Lund University

August 1989 - October 1995

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Jack T. Rogers, Xudong Huang, Lee E. Goldstein, Juliet A. Moncaster, Debomoy K. Lahiri, Catherine M. Cahill, Hyun-Hee Cho, Marlies Fischer, Marcie A. Glicksman, Greg D. Cuny, et al.(2009). Specific {APP} translation blockers as a therapeutic intervention for Alzheimer{\textquotesingle}s disease . Alzheimer{\textquotesingle}s {\&} Dementia. 5. (4). p. P138--P139. Elsevier {BV}
Xie Y, Liu Y, Gong G, Smith DH, Yan F, Rinderspacher A, Feng Y, Zhu Z, Li X, Deng SX, Branden L, Vidović D, Chung C, Schürer S, Morisseau C, Hammock BD, Landry DW, Bioorganic & medicinal chemistry letters, 2009, vol. 19, no. 8, pp. 2354-2359 .
Olivares D, Huang X, Branden L, Greig NH, Rogers JT, International journal of molecular sciences, 2009, vol. 10, no. 3, pp. 1226-1260 .
Rinderspacher A, Cremona ML, Liu Y, Deng SX, Xie Y, Gong G, Aulner N, Többen U, Myers K, Chung C, Andersen M, Vidović D, Schürer S, Brandén L, Yamamoto A, Landry DW, Bioorganic & medicinal chemistry letters, 2009, vol. 19, no. 6, pp. 1715-1717 .
Gong G, Xie Y, Liu Y, Rinderspacher A, Deng SX, Feng Y, Zhu Z, Tang Y, Wyler M, Aulner N, Toebben U, Smith DH, Branden L, Chung C, Schürer S, Vidović D, Landry DW, Bioorganic & medicinal chemistry letters, 2009, vol. 19, no. 4, pp. 1191-1194 .
Xie Y, Rinderspacher A, Liu Y, Gong G, Smith DH, Wyler M, Brandén L, Deng SX, Current topics in medicinal chemistry, 2009, vol. 9, no. 13, pp. 1172-1180 .
Xie Y, Liu Y, Gong G, Rinderspacher A, Deng SX, Smith DH, Toebben U, Tzilianos E, Branden L, Vidović D, Chung C, Schürer S, Tautz L, Landry DW, Bioorganic & medicinal chemistry letters, 2008, vol. 18, no. 9, pp. 2840-2844 .
Yuli Xie, Gangli Gong, Yidong Liu, Shixian Deng, Alison Rinderspacher, Lars Branden, Donald W. Landry(2008). Convenient preparation of N-8-quinolinyl benzenesultams as novel {NF}-$\upkappa$B inhibitors . Tetrahedron Letters. 49. (14). p. 2320--2323. Elsevier {BV}
Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS, Bioorganic & medicinal chemistry letters, 2008, vol. 18, no. 1, pp. 329-335 .
Brandén LJ, Assay and drug development technologies, 2007, vol. 5, no. 4, pp. 465-471 .
Mayer T, Jagla B, Wyler MR, Kelly PD, Aulner N, Beard M, Barger G, Többen U, Smith DH, Brandén L, Rothman JE, Methods in enzymology, 2006, vol. 414, pp. 266-283 .
Svahn MG, Salih G, Simonson EO, Smith CI, Brandén LJ, Journal of controlled release : official journal of the Controlled Release Society, 2004, vol. 98, no. 1, pp. 169-177 .
Lundin KE, Ge R, Svahn MG, Törnquist E, Leijon M, Brandén LJ, Smith CI, Biomolecular engineering, 2004, vol. 21, no. 2, pp. 51-59 .
Svahn MG, Lundin KE, Ge R, Törnquist E, Simonson EO, Oscarsson S, Leijon M, Brandén LJ, Smith CI, The journal of gene medicine, 2004, vol. 6 Suppl 1, pp. S36-44 .
Odeberg J, Plachter B, Brandén L, Söderberg-Nauclér C, Blood, 2003, vol. 101, no. 12, pp. 4870-4877 .
Odeberg J, Browne H, Metkar S, Froelich CJ, Brandén L, Cosman D, Söderberg-Nauclér C, Journal of virology, 2003, vol. 77, no. 8, pp. 4539-4545 .
Imreh G, Maksel D, de Monvel JB, Brandén L, Hallberg E, Experimental cell research, 2003, vol. 284, no. 2, pp. 173-184 .
Tahmina C. Islam, Jessica Lindvall, Anders Wennborg, Lars J. Brandén, Hodjatallah Rabbani, C. I. Edvard Smith(2002). Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays . European Journal of Immunology. 32. (4). p. 982--993. Wiley-Blackwell
Tahmina C. Islam, Jessica Lindvall, Anders Wennborg, Lars J. Brandén, Hodjatallah Rabbani, C. I. Edvard Smith(2002). Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays . European Journal of Immunology. 32. (4). p. 982--993. Wiley-Blackwell
Islam TC, Lindvall J, Wennborg A, Brandén LJ, Rabbani H, Smith CI, European journal of immunology, 2002, vol. 32, no. 4, pp. 982-993 .
Brandén LJ, Smith CI, Methods in enzymology, 2002, vol. 346, pp. 106-124 .
Brandén LJ, Christensson B, Smith CI, Gene therapy, 2001, vol. 8, no. 1, pp. 84-87 .
Lars Brandén(2000). {PNA}: a universal tool in molecular biology . Trends in Biotechnology. 18. (8). p. 361. Elsevier {BV}
Tahmina C. Islam, Lars J. Brandén, Donald B. Kohn, Khalid B. Islam, C. I. Edvard Smith(2000). {BTK} mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones. J. Gene Med. 2. (3). p. 204--209. Wiley-Blackwell
Beston F. Nore, Leonardo Vargas, Abdalla J. Mohamed, Lars J. Brandén, Carl-Magnus Bäckesjö, Tahmina C. Islam, Pekka T. Mattsson, Kjell Hultenby, Birger Christensson, C. I. Edvard Smith(2000). Redistribution of Bruton{\textquotesingle}s tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family {GTPases} . European Journal of Immunology. 30. (1). p. 145--154. Wiley-Blackwell
Nore BF, Vargas L, Mohamed AJ, Brandén LJ, Bäckesjö CM, Islam TC, Mattsson PT, Hultenby K, Christensson B, Smith CI, European journal of immunology, 2000, vol. 30, no. 1, pp. 145-154 .
Beston F. Nore, Leonardo Vargas, Abdalla J. Mohamed, Lars J. Brandén, Carl-Magnus Bäckesjö, Tahmina C. Islam, Pekka T. Mattsson, Kjell Hultenby, Birger Christensson, C. I. Edvard Smith(2000). Redistribution of Bruton{\textquotesingle}s tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family {GTPases} . European Journal of Immunology. 30. (1). p. 145--154. Wiley-Blackwell
Beston Nore, Abdalla Mohamed, Leonardo Vargas, Lars Brandén, Carl-Magnus Bäckesjö, Mauno Vihinen, Birger Christensson, C. Smith(2000). The Role of Bruton{\textasciiacute}s Tyrosine Kinase (Btk) in Phosphoinositide-Dependent Signaling . Allergy {\&} Clinical Immunology International - Journal of the World Allergy Organization. 12. (3). p. 0126--0133. Hogrefe {\&} Huber
Brandén LJ, Mohamed AJ, Smith CI, Nature biotechnology, 1999, vol. 17, no. 8, pp. 784-787 .
Vihinen M, Brandau O, Brandén LJ, Kwan SP, Lappalainen I, Lester T, Noordzij JG, Ochs HD, Ollila J, Pienaar SM, Riikonen P, Saha BK, Smith CI, Nucleic acids research, 1998, vol. 26, no. 1, pp. 242-247 .
Smith CI, Bäckesjö CM, Berglöf A, Brandén LJ, Islam T, Mattsson PT, Mohamed AJ, Müller S, Nore B, Vihinen M, Springer seminars in immunopathology, 1998, vol. 19, no. 4, pp. 369-381 .
Sideras P, Müller S, Shiels H, Jin H, Khan WN, Nilsson L, Parkinson E, Thomas JD, Brandén L, Larsson I, Journal of immunology (Baltimore, Md. : 1950), 1994, vol. 153, no. 12, pp. 5607-5617 .
OTHER
Thomas Mayer, Bernd Jagla, Michael R. Wyler, Peter D. Kelly, Nathalie Aulner, Matthew Beard, Geoffrey Barger, Udo Többen, Deborah H. Smith, Lars Brandén, et al.(2006). Cell-Based Assays Using Primary Endothelial Cells to Study Multiple Steps in Inflammation . 266--283Elsevier {BV}
Lars J. Branden, C.I.Edvard Smith(2002). [6] Bioplex technology: Novel synthetic gene delivery system based on peptides anchored to nucleic acids . 106--124Elsevier {BV}